Y-27632 activity on the regulation of the cytoskeleton was first demonstrated in inflammatory diseases [182] and then exploited later on to mitigate WNT5A-dependent cell migration in preclinical models of classical Hodgkin’s disease (cHL) [183]. This evidence concerns the gene WNT5A and classic Hodgkin lymphoma.